To be sure, cancer remains far from “cured,” and many formidable scientific obstacles remain. We’re nevertheless moving steadily from merely treating cancers to eliminating them with extraordinary ...

The U.S. national debt just crossed the $40 trillion threshold, doubling in less than a decade. Washington politicians have responded with their favorite fiscal game: blaming the other party.

There has been a lot of commentary on the differences between Resistance 1.0, the effort by anti-Trump activists to bring down President Donald Trump in his first term, and Resistance 2.0, the effort ...

The main way to limit the negative impact of the debt is through growth, prosperity and a rise in asset values. What matters most for a household, a business or a government is how much debt you owe ...

Democrats hope to press the "affordability" issue in this year's midterm election season, but there's one potentially glaring problem for them, as illustrated by our friends at Unleash Prosperity ...

Your browser does not support PDFs. Download the PDF.

Those who can, do; those who can't, teach. A similar idea underscores the debate over wealth taxes in California and elsewhere: Those who can, build companies. Those who can't, devise ways for the ...

S]he can't manage her personal finances well enough to pay back her student loans. It's crazy to trust her with the nation's finances.

Washington spent hundreds of billions of dollars on taxpayer subsidies to promote wind and solar, yet it remained as stalled out as the EV plants that are shutting down across the country.

The big picture on the speech is that it showed Trump struggling with the war at a time when he needs to present a picture of strength and confidence to voters deciding what Congress will look like ...

Under a president who made law and order central to his political identity, America just recorded the largest violent-crime decline in modern statistical history.

In our latest Liberty Update, CFIF highlights the debut of the “Most Favored Patient” initiative, which offers the optimal blueprint going forward for lower drug costs, greater access and better ...